• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-21

  Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used for research workflows only, not for diagnostic, therapeutic, or medical applications, and no directly matched paper-specific validation is supplied.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-20

  A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of transcriptomic discovery, molecular validation, and macrophage-specific RXRα knockdown provides a useful framework for testing how nuclear receptor signaling connects vascular inflammation with protein ubiquitination.

• N-octanoyl-L-Homoserine lactone: Assay Logic

  2026-08-20

  N-octanoyl-L-Homoserine lactone, or C8-HSL, connects bacterial quorum sensing with host-cell signaling. This assay-first guide explains how to distinguish biofilm, virulence, and cancer-cell phenotypes while translating recent PI3K/AKT/ERK findings into better experimental decisions.

• Lenalidomide and DOT1L: Reprogramming Myeloma Immunity

  2026-08-19

  Lenalidomide research is moving beyond broad immunomodulation toward biomarker-guided combination biology. This thought-leadership guide examines how DOT1L-dependent innate immune signaling may shape CC-5013 response in multiple myeloma and translates the findings into practical assay and development strategies.

• Z-IETD-FMK: Mapping Caspase-8 in Immunity

  2026-08-19

  A translational framework for using Z-IETD-FMK to dissect caspase-8-dependent apoptosis, T cell activation, NF-κB signaling, and TRAIL responses while connecting infection biology with immune and cancer research.

• N-octanoyl-L-Homoserine lactone Assay Guide

  2026-08-18

  A scenario-based guide to using N-octanoyl-L-Homoserine lactone (SKU C3579) in viability, proliferation, cytotoxicity, and host–microbe experiments. It covers solvent compatibility, concentration planning, interpretation of C8-HSL-driven phenotypes, and practical product-selection criteria.

• Ruxolitinib (INCB018424) Assay Workflows

  2026-08-18

  Build pathway-resolved experiments with Ruxolitinib (INCB018424) across JAK-driven hematopoietic models and inflammatory monocyte assays. This practical guide connects dose selection, phospho-signaling, flow cytometry, and troubleshooting without treating a TLR4 study as direct evidence for JAK inhibition.

• BX795: PDK1 Inhibitor Workflows for Cancer

  2026-08-17

  BX795 supports acute, titratable interrogation of PDK1–AKT2 signaling while also enabling studies of TBK1, IKKε, and IRF3-dependent innate immunity. This guide pairs practical kinase, cancer-cell, and macrophage workflows with assay-design choices that distinguish growth arrest from true cell killing.

• 1-Phenyl-2-Pentanol and Hepatic Fibrosis

  2026-08-17

  The reference study evaluates 1-phenyl-2-pentanol, a compound identified from Moringa oleifera leaves, in TGF-β1-stimulated human hepatic stellate cells. By combining fibrosis-marker analysis, proteomics, and molecular docking, it links the compound’s anti-fibrotic activity to suppression of TGF-β1 and Wnt/β-catenin signaling while highlighting important limits of an in vitro model.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-08-16

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research tool for examining autophagy pathway modulation and toll-like receptor 7/9 signaling in autoimmune disease research. It is suited to short-term, water-based workflows, but should not be selected for protocols that require DMSO or ethanol solubility or long-term storage of prepared solutions.

• Urolithin A Workflows for Fibrosis Research

  2026-08-15

  Build a mitochondria-centered hepatic stellate cell workflow with Urolithin A while preserving the glutamine-metabolism logic established in liver fibrosis research. The approach separates mitophagy and respiratory effects from direct GDH inhibition, enabling cleaner mechanism-of-action studies and more reliable troubleshooting.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-14

  The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, supports reproducible HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is a research-use, unconjugated reagent and should not be used for diagnostic, therapeutic, or unvalidated live-cell applications.

• WIP1, p38 MAPK, and Pyroptosis in Septic AKI

  2026-08-14

  A 2024 Immunobiology study identifies WIP1/PPM1D as an endogenous brake on p38 MAPK-associated pyroptosis in sepsis-associated acute kidney injury. Using single-cell sequencing, LPS injury models, and pharmacological inhibition, the authors connect WIP1 activity with renal tubular protection while highlighting p38 MAPK as a mechanistic intermediary.

• Pentoxifylline in Macrophage Inflammation Research

  2026-08-13

  Pentoxifylline provides a practical way to connect phosphodiesterase inhibition with cAMP elevation, nitric oxide suppression, and macrophage-state changes. This guide translates a landmark macrophage study into reproducible workflows for inflammation, psoriasis, and translational immune-model research, with concentration selection and troubleshooting built in.

• Ruxolitinib in Immune Profiling Workflows

  2026-08-13

  Ruxolitinib (INCB018424) provides a focused way to perturb JAK1/2 signaling while measuring tumor-cell growth and immune-state changes. This workflow translates a high-dimensional murine sarcoma study into practical guidance for progenitor assays, oncogenic JAK2 models, spectral cytometry, and combination-therapy experiments.

16194 records 1/1080 page Next 12345 下5页 Last page